The Rising Government Investment to Foster the Growth of the Global Oligonucleotide Synthesis Market

Published: Apr 2020

The global oligonucleotide synthesis market is anticipated to grow at a considerable CAGR of 11.0% during the forecast period (2021-2027). The speeding up in government investment is one of the prime factors affecting and driving the market. Various governments of different countries had been playing a remarkable role in recent years through their investment in different projects associated with synthetic biology and genomics along with the development of the latest technologies which in turn is driving the growth of the market.

Browse the full report description of "Global Oligonucleotide Synthesis Market Research By Product (Synthesized Oligonucleotides, Reagents, and Equipment), By Type (Custom Oligos and Predesigned Oligos), and By End-User (Hospitals, Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Other) Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/oligonucleotide-synthesis-market

For instance, in February 2021, the Centre for Process Innovation (CPI) in the UK had introduced a project in the Medicines Manufacturing Innovation Centre with the objective to revolutionize the manufacturing of oligonucleotides with the collaboration with AstraZeneca, Exactmer, Novartis, and the UK Research & Innovation. Through this collaboration, a small interfering RNA named Inclisiran will be the first medicine made at a commercial scale resulting to be utilized for giving proper and effective treatment for a person suffering from atherosclerotic cardiovascular disease (ASCVD). Further, the key players present in the global oligonucleotide synthesis market had been adopting various strategies that include mergers and acquisitions to gain major market share.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Device Type

o By Payer

o By End-User

    • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape- Danaher Corp., Thermo Fisher Scientific Inc., Merck KgaA, Maravai LifeSciences, and GenScript.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Oligonucleotide Synthesis Market 

By Product

    • Synthesized Oligonucleotides

    • Reagents

    • Equipment

By Type

    • Custom Oligos

    • Predesigned Oligos

By End-User

    • Hospitals

    • Pharmaceutical & Biotechnology Companies

    • Academic Research Institutes

    • Other (Diagnostic Laboratories)

Global Oligonucleotide Synthesis Market by Region 

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/oligonucleotide-synthesis-market